Introducing IR patients to electronic outcome reporting increases likelihood they complete follow-up survey

Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.

After initial introduction to electronic quality-of-life (QOL) questionnaires for deep vein thrombosis and lymphedema, patients were more likely to complete the questionnaires remotely for their follow-up appointment, according to new research published in the Journal of the American College of Radiology.

Edwards Announces Start Of U.S. Study Of Self-Expanding Transcatheter Heart Valve

IRVINE, Calif., Oct. 8, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has commenced the U.S. pivotal trial that will study its self-expanding CENTERA transcatheter valve for severe, symptomatic aortic stenosis (AS) patients at intermediate risk of open-heart surgery.